|Bid||142.80 x 0|
|Ask||143.20 x 0|
|Day's Range||142.60 - 144.40|
|52 Week Range||114.70 - 167.60|
|Beta (5Y Monthly)||-0.01|
|PE Ratio (TTM)||23.44|
|Earnings Date||Jul 29, 2020|
|Forward Dividend & Yield||0.06 (4.13%)|
|Ex-Dividend Date||Oct 08, 2020|
|1y Target Est||125.21|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Every investor in Primary Health Properties PLC (LON:PHP) should be aware of the most powerful shareholder groups...
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property (IP) portfolio as European Patent Application No. 14851547.1 has been granted. The patent will be set to expire in October 7, 2034, subject to patent term adjustment or extension.